Interaction of macrolides with αdornase during DNA hydrolysis

Journal of Antimicrobial Chemotherapy

Volumn 37, Issue 5, 1996, Pages 987-991

  Ripoll, Laurent ^a   Reinert, Philippe ^b   Pépin, Louis Ferdinand ^c   Lagrange, Philippe H ^a  

^a SAINT LOUIS HOSPITAL   (France)

^b CENTRE HOSPITALIER INTERCOMMUNAL DE CRÉTEIL   (France)

^c PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; DNA; DORNASE ALFA; ERYTHROMYCIN; MACROLIDE; ROXITHROMYCIN;

ARTICLE; CYSTIC FIBROSIS; DRUG ACTIVITY; HUMAN; HUMAN TISSUE; HYDROLYSIS; RESPIRATORY TRACT INFECTION; SPUTUM; VISCOSITY;

AZITHROMYCIN; DEOXYRIBONUCLEASE I; DNA; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; ERYTHROMYCIN; HUMANS; HYDROLYSIS; KINETICS; RECOMBINANT PROTEINS; ROXITHROMYCIN;

EID: 0029996948     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/37.5.987     Document Type: Article

References (10)

1. Adams, R. L. P., Knowler, J. T. & Leader, D. P. (1986). The structure of the nucleic acids. In The Biochemistry of the Nucleic Acids, 10th edn, pp. 20-1. Chapman and Hall, London.
2. Arévalo, M. A., Tejedor, F., Polo, F. & Ballesta, J. P. (1988). Protein components of the erythromycin binding site in bacterial ribosomes. Journal of Biological Chemistry 263, 58-63.
3. Baldwin, D. R., Wise, R., Andrews, J. M., Ashby, J. P. & Honeybourne, D. (1990). Azithromycin concentrations at the sites of pulmonary infection. European Respiratory Journal 3, 886-90.
4. Hubbard, R. C., McElvaney, N. G., Birrer, P., Shak, S., Robinson, W. W., Jolley, C. et al. (1992). A preliminary study of aerosolized recombinant human deoxyribonuclease I in the treatment of cystic fibrosis. New England Journal of Medicine 326, 812-5.
5. Kobayashi, H. (1995). Airway biofilm disease: its clinical manifestation and therapeutic possibilities of macrolides. Journal of Infection and Chemotherapy 1, 1-15.
6. Molinari, G., Guzman, C. A., Pesce, A. & Schito, G. C. (1993). Inhibition of Pseudomonas aeruginosa virulence factors by subinhibitory concentrations of azithromycin and other macrolides antibiotics. Journal of Antimicrobial Chemotherapy 31, 681-8.
7. Oishi, K., Sonoda, F., Kobayashi, S., Iwagaki, A., Nagatake, Y., Matsushima, K. et al. (1994). Role of interleukin-8 (IL-8) and an inhibitory effect of erythromycin on IL-8 release in the airways of patients with chronic airway diseases. Infection and Immunity 62, 4145-52.
8. Ramsey, B. W., Astley, S. J., Aitken, M. L., Burke, W., Colin, A. A., Dorkin, H. L. et al. (1993). Efficacy and safety of short-term administration of aerosolized recombinant human deoxy-ribonuclease in patients with cystic fibrosis. American Review of Respiratory Diseases 148, 145-51.
9. Ranasinha, C., Assoufi, B., Shak, S., Christiansen, D., Fuchs, H., Empey, D. et al. (1993). Efficacy and safety of short-term administration of aerosolized recombinant human DNase in adults with stable stage cystic fibrosis. Lancet 342, 199-202.
10. Shak, S. (1995). Aerosolized recombinant human DNase I for the treatment of cystic fibrosis. Chest 107, Suppl. 2, 65-70.